We are facing a new threat to global health. The COVID-19 pandemic made it clear to health-care providers, public health practitioners, policy makers, and communities that pathogens do not respect ...
The viral illness kills more people in the city than HIV, but antiviral medications may be helping cut its transmission.
GSK is prioritizing development of its hepatitis B treatment bepirovirsen as the pharma ends work on another potential ...
New model predicts HCC risk in noncirrhotic chronic hepatitis B patients, improving early detection strategies.
The Philadelphia Department of Public Health has released its 2023 Annual Report on Hepatitis B, C, and D in the city. The ...
Viral hepatitis is a major danger to public health. According to WHO’s 2024 Global Hepatitis Report, viral hepatitis deaths ...
Discover a clinical trial that was conducted to evaluate the efficacy and safety of autologous HBV vaccine-pulsed dendritic cells and their induced T cells.
The company will use the funding to advance clinical trials for Tune-401, the epigenetic silencing drug for treating chronic ...
In a new clinical practice guideline, the AGA provided evidence-based recommendations for either antiviral prophylaxis or continued surveillance to manage hepatitis B virus reactivation in patients ...
Egypt's Minister of Health and Population Khaled Abdel Ghaffar announced that the country has met the regional target for hepatitis B control set by the WHO's Regional Committee during its 56th ...
In addition, if you are pregnant, speak with your healthcare provider about which vaccine is right for you. Hepatitis B is a viral infection that causes inflammation of the liver. In rare cases, ...
Breakthrough therapy designation recognises the potential of brelovitug to transform the lives of people living with CHD. We look forward to initiating a global pivotal trial a ...